Proteome will combine its three-stage mass spectrometry (MS3) fragmentation methodology with Thermo Fisher's Orbitrap mass spectrometer technology to develop cancer pathway profiling assays

Proteome Sciences plc

U.K. / Tools, Services, and Manufacturing

$173.2m on 06/21/2013 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Thermo Fisher Scientific Inc.

U.S. / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced